Drug Response Diversity: A Hidden Bacterium? - Aix-Marseille Université Access content directly
Journal Articles Journal of Personalized Medicine Year : 2021

Drug Response Diversity: A Hidden Bacterium?


Interindividual heterogeneity in response to treatment is a real public health problem. It is a factor that can be responsible not only for ineffectiveness or fatal toxicity but also for hospitalization due to iatrogenic effects, thus increasing the cost of patient care. Several research teams have been interested in what may be at the origin of these phenomena, particularly at the genetic level and the basal activity of organs dedicated to the inactivation and elimination of drug molecules. Today, a new branch is being set up, explaining the enigmatic part that could not be explained before. Pharmacomicrobiomics attempts to investigate the interactions between bacteria, especially those in the gut, and drug response. In this review, we provide a state of the art on what this field has brought as new information and discuss the challenges that lie ahead to see the real application in clinical practice.
Fichier principal
Vignette du fichier
jpm-11-00345.pdf (1.61 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Licence : CC BY - Attribution

Dates and versions

hal-03280467 , version 1 (26-06-2023)





Nadji Hannachi, Laurence Camoin-Jau. Drug Response Diversity: A Hidden Bacterium?. Journal of Personalized Medicine, 2021, 11 (5), pp.345. ⟨10.3390/jpm11050345⟩. ⟨hal-03280467⟩


23 View
0 Download



Gmail Facebook Twitter LinkedIn More